Clinical Trial Update: BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating BRCA1-associated DNA repair dysfunction in patients with early triple-negative breast cancer treated with neoadjuvant p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: Early Triple Negative Breast Cancer | Phase 2 | Status: COMPLETED